MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Mixed Phenotype Acute Leukemia

  1. Home
  2. Diseases
  3. Mixed Phenotype Acute Leukemia
  4. Clinical Trials

Clinical Trials Related to Mixed Phenotype Acute Leukemia

Related studies linked through entity extraction aliases.

NCT03007147

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE3

NCT02921061

Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT02828358

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

Status
COMPLETED
Phase
PHASE2

NCT02135874

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia

Status
COMPLETED
Phase
PHASE2

NCT01887587

Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia

Status
TERMINATED
Phase
PHASE1

NCT00723099

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Status
COMPLETED
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.